A team of U.S. and Canadian researchers reports finding no increased cancer risk among patients who take rheumatoid arthritis drugs called TNF blockers, such as Remicade, Enbrel and Humira. Rheumatoid arthritis sufferers do have higher rates of cancer, but the scientists said that problem was not linked to the drugs.

Full Story:

Related Summaries